4.2 Review

Heavy Metal in the Intensive Care Unit: A Review of Current Literature on Trace Element Supplementation in Critically Ill Patients

Journal

NUTRITION IN CLINICAL PRACTICE
Volume 29, Issue 1, Pages 78-89

Publisher

WILEY
DOI: 10.1177/0884533613515724

Keywords

minerals; trace elements; critical care; sepsis; micronutrients; nutritional support

Ask authors/readers for more resources

Trace elements are essential for many physiologic processes. In recent years, supplementation has been studied for a variety of indications, including glycemic control, wound healing, antioxidant effect, and anemia. Critical illness, especially states such as burns, traumas, and septic shock, is associated with inflammatory and oxidative stress, immune dysfunction, and malnutrition. In these patients, enteral and parenteral nutrition or pharmaceutical supplementation is used to provide essential macronutrients, including trace elements. The purpose of this review is to describe trace element supplementation, including iron, copper, chromium, manganese, selenium, and zinc, and highlight their mechanism, pharmacology, outcome data, and adverse effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Meeting Abstract Critical Care Medicine

Diphenhydramine as an Adjunct to Conscious Sedation in Bronchoscopy

Rodeo Abrencillo, Michael Simoff, Tom Smoot, Cyndi Ray, Mohammed Aljasmi, Jennings Jeffery, Lenar Yessayan

CHEST (2016)

Meeting Abstract Emergency Medicine

Skip the Drip: Oral Diltiazem for Rate Control in Rapid Atrial Fibrillation

A. Markin, T. Smoot, B. Fiechter, J. Miller

ANNALS OF EMERGENCY MEDICINE (2018)

Article Emergency Medicine

A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome

Diana J. Dean, Noor Sabagha, Kaitlin Rose, Alexander Weiss, John France, Timothy Asmar, Jo-Ann Rammal, Margaret Beyer, Rebecca Bussa, Jacob Ross, Kaleem Chaudhry, Thomas Smoot, Kathleen Wilson, Joseph Miller

ACADEMIC EMERGENCY MEDICINE (2020)

Article Pharmacology & Pharmacy

INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies

Frank M. P. van Haren, Alice Richardson, Hwan-Jin Yoon, Antonio Artigas, John G. Laffey, Barry Dixon, Roger Smith, Alicia B. Vilaseca, Ruben A. Barbera, Tarek I. Ismail, Rabab S. Mahrous, Mohamed Badr, Gilberto De Nucci, Carlos Sverdloff, Lex M. van Loon, Marta Camprubi-Rimblas, David W. Cosgrave, Thomas L. Smoot, Sabrina Staas, Khine Sann, Caitlin Sas, Anusha Belani, Christopher Hillman, Janis Shute, Mary Carroll, Tom Wilkinson, Miles Carroll, Dave Singh, Clive Page

Summary: The study aims to investigate the therapeutic potential of inhaled nebulised unfractionated heparin in COVID-19 patients, with research conducted in multiple countries. The primary outcome is to observe intubation or death within 28 days, while secondary outcomes include oxygenation, clinical worsening, and mortality.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients

Frank M. P. van Haren, Lex M. van Loon, Anne Steins, Thomas L. Smoot, Caitlin Sas, Sabrina Staas, Alicia B. Vilaseca, Ruben A. Barbera, Gustavo Vidmar, Hugo Beccari, Frida Popilevsky, Eleonora Daribayeva, Bhuvaneshwari Venkatesan, Susan Mozes, Rachel Postel, Natalie Popilevski, Andrew Webb, Quentin Nunes, John G. Laffey, Antonio Artigas, Roger Smith, Barry Dixon, Alice Richardson, Hwan-Jin Yoon, Clive Page

Summary: This study retrospectively evaluated the safety and efficacy potential of inhaled nebulised UFH in hospitalised patients with COVID-19. The results showed improvement in oxygenation levels with inhaled UFH, but no clinically significant increase in APTT. Patients receiving therapeutic anticoagulation had a higher risk of adverse events.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

No Data Available